TrumpRx

Product

Last mentioned: Feb 25, 2026

Timeline

  1. Operational Launch

    The new facilities are expected to come online and begin API production.

  2. Construction Start

    Anticipated groundbreaking for the two new manufacturing plants.

  3. Manufacturing Expansion

    AbbVie announces $380 million investment for North Chicago API facilities.

  4. $100B Pledge

    AbbVie commits to $100 billion in U.S. R&D and capital investments over the next decade.

Stories mentioning TrumpRx 1

Manufacturing Bullish

AbbVie Commits $380M to U.S. API Production in $100B Supply Chain Pivot

AbbVie has announced a $380 million investment to expand active pharmaceutical ingredient (API) manufacturing in North Chicago, marking the first major step in a $100 billion decade-long commitment to U.S. R&D and production. The move aligns with federal efforts to reshore critical drug supply chains and lower costs through direct-to-patient channels like TrumpRx.

3 sources